IFNG and cancer: Lack of CD16 expression in tumor-residing NK cells is in line with previous reports on decreased CD16 expression after NK cell interactions with cancer stem-like cells34, demonstrating impairment of NK cell cytotoxicity but increasing IFN-γ secretion.